AbulKalam M. Shamsuddin, MD, PhD is President of IP-6 Research, Inc. (www.ip-6.net).

He retired from the University of Maryland, School of Medicine, Baltimore after 43 years as Professor of Pathology in June 2020.

Prof Shamsuddin graduated from Dhaka Medical College, University of Dhaka in 1972.

Following Internship in Massachusetts and Residency training in Pathology at the Johns Hopkins- and University of Maryland-affiliated hospitals, he was certified by the American Board of Pathology in 1977. In 1980, he received PhD. from the University of Maryland for his work on carcinogenesis. He joined the faculty of the University of Maryland as an Instructor in 1977 and rose through the ranks of Assistant Professor and Associate Professor with tenure to become a full Professor in 1988. He was a Senior Scientist at the Laboratories of Experimental Pathology and Human Carcinogenesis, National Cancer Institute, Bethesda, MD 1981-1982.

He had invented a simple test for mass screening of cancers of the colon, breast, lungs, prostate, uterus and pancreas. He co-founded Early Detection, Inc. (EDI) to commercialize the test and serve as a member of the Board of Directors. He also performed pioneering experiments on the anti-cancer property of inositol and inositol

hexaphosphate (IP 6 ) - natural constituents of cereals and legumes such as rice, corn,beans etc. to show the efficacy of IP 6 and inositol against different cancers in various experimental models. 

Prof Shamsuddin has written three books on the subject IP 6 : Nature's Revolutionary Cancer Fighter, IP 6 + Inositol: Nature’s Medicine for the Millennium and Inositol and It’s Phosphates: Basic Science to Practical Applications.

Aside from these Prof Shamsuddin has contributed numerous book-chapters and

published over 200 scientific papers. He is a well sought-after lecturer nationally and internationally.